COVID-19 vaccine hesitancy and resistance in an urban Chinese population of Hong Kong: a cross-sectional study.
Hum Vaccin Immunother
; 18(5): 2072144, 2022 11 30.
Article
in English
| MEDLINE | ID: covidwho-1864929
ABSTRACT
Vaccine hesitancy against COVID-19 is prevalent. This study aimed to identify the factors associated with COVID-19 vaccination compliance among adults in Hong Kong. An online survey was conducted during an early stage of community-based COVID-19 vaccination campaign in Hong Kong. The questionnaire consisted of vaccine status, sociodemographic information, risk perception of being infected by COVID-19, and exposure to confirmed COVID cases, as well as items on sleep and mental health. The association between these variables and vaccine hesitancy was analyzed. Among the 883 participants (67.5% females, 54.5% aged 18-39), 30.6% had low vaccine hesitancy, 27.4% had high vaccine hesitancy, and 27.5% had vaccine rejection. The likelihood of having high vaccine hesitancy was higher among young (adjusted odds ratio [aOR] = 2.99; 95% confidence interval [CI] 1.23-7.30) and middle-aged respondents (aOR = 2.99; 95% CI 1.07-5.47) than among old respondents. Moreover, those who were married (aOR = 0.51; 95% CI 0.29-0.88), had a full-time job (aOR = 0.55; 95% CI 0.29-0.88), and had a greater confidence in the government (aOR = 0.68; 95% CI 0.54-0.86) were less likely to exhibit vaccine hesitancy. Our findings showed that the prevalence of vaccine hesitancy and vaccine resistance were high. Policy makers need specific strategies to target those who may have a high risk of vaccine hesitancy and resistance.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
Hum Vaccin Immunother
Year:
2022
Document Type:
Article
Affiliation country:
21645515.2022.2072144
Similar
MEDLINE
...
LILACS
LIS